BriaCell Therapeutics Corp Warrant
BCTXW
BCTXW was delisted on the 26th of February, 2026.
6 hedge funds and large institutions have $12.7K invested in BriaCell Therapeutics Corp Warrant in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0.48% more ownership
Funds ownership: 5.11% → 5.59% (+0.48%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
14% less funds holding
Funds holding: 7 → 6 (-1)
16% less capital invested
Capital invested by funds: $15.1K → $12.7K (-$2.48K)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$2.05K |
| 2 |
HF
HRT Financial
New York
|
+$1.92K |
| 3 |
NFSG
Newbridge Financial Services Group
Boca Raton,
Florida
|
+$90 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.44K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$215 |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$72 |
| 4 |
CS
Clear Street
New York
|
-$10 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RAM
1
Redmond Asset Management
Henrico,
Virginia
| $5.65K | – | – | – |
|
|
TSS
2
Two Sigma Securities
New York
| $4.03K | +$2.05K | +22,657 | +73% |
|
|
AC
3
Armistice Capital
New York
| $1.88K | – | – | – |
|
|
HF
4
HRT Financial
New York
| $1K | +$1.92K | +21,248 | New |
|
|
NFSG
5
Newbridge Financial Services Group
Boca Raton,
Florida
| $75 | +$90 | +1,000 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $24 | -$215 | -2,375 | -88% |
|
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$1.44K | -16,246 | Closed |
|
|
8
Osaic Holdings
Scottsdale,
Arizona
| – | -$72 | -800 | Closed |
|
|
CS
9
Clear Street
New York
| – | -$10 | -100 | Closed |
|
BCTXW Hedge Fund Activity: Q2 2025 in Review
6 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in BriaCell Therapeutics Corp Warrant (BCTXW) for Q2 2025, worth a combined $12.7K — down 16% from $15.1K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BCTXW and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Two Sigma Securities, adding an estimated $2.05K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $1.44K sold.
- 6 institutional investors held BriaCell Therapeutics Corp Warrant (BCTXW) as of Q2 2025, down from 7 in Q1 2025.
- Funds reported $12.7K of BriaCell Therapeutics Corp Warrant stock for Q2 2025, down 16% quarter-over-quarter.
- 2 funds opened new BriaCell Therapeutics Corp Warrant positions in Q2 2025 and 3 closed out, a net change of -1 holder.
- The largest BriaCell Therapeutics Corp Warrant buyer in Q2 2025 was Two Sigma Securities, an estimated $2.05K added.
- The largest BriaCell Therapeutics Corp Warrant seller in Q2 2025 was Susquehanna International Group, an estimated $1.44K sold.
Based on aggregated 13F filings for Q2 2025.